[Candida infection in hip alloarthroplasty]

K L Prenzel1, J Isenberg, H J Helling

  • 1Klinik für Unfall-, Hand- und Wiederherstellungschirurgie,Klinikum der Universität zu Köln, Cologne.

Der Unfallchirurg
|January 29, 2003
PubMed

Insights

A challenging hip replacement infection involving multiple pathogens was successfully treated with antifungal therapy and a staged revision approach. This case highlights effective management of complex prosthetic joint infections.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Medical Microbiology

Background:

  • Necrosis of the femoral head necessitates total hip replacement (THR).
  • Patients with polytoxicomania, diabetes, and polyneuropathy present complex comorbidities.
  • Prosthetic joint infections (PJIs) are a significant complication following THR.

Observation:

  • A 46-year-old polytoxicomanic patient developed a deep wound infection post-THR, initially involving Staphylococcus aureus, Enterococcus, and Candida parapsilosis.
  • Despite multiple revision surgeries, antibiotics, and drainage, the infection persisted.
  • Subsequent cultures after prosthesis removal and PMMA spacer insertion revealed Candida albicans.

Findings:

  • Antifungal therapy with fluconazole eradicated Candida albicans infection.
  • A staged revision involving a temporary spacer and subsequent prosthesis reimplantation was successful.
  • The patient remained infection-free at the final follow-up.

Implications:

  • This case demonstrates the successful management of a polymicrobial prosthetic joint infection with a specific focus on fungal eradication.
  • Staged revision arthroplasty with appropriate antimicrobial therapy is a viable strategy for complex PJIs.
  • The importance of thorough microbiological investigation and tailored treatment in recalcitrant infections is emphasized.